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Major depression and chronic kidney disease in
PakistanNon-communicable diseases (NCDs) have a significant global
impact, being responsible for 60% of all deaths and 47% of
the global burden of disease. In South Asia, almost half of
the adult burden of disease falls into the NCD category.1 In
Pakistan, NCDs contribute significantly to the disease
burden, ranking among the top 10 causes of mortality and
morbidity. Estimates indicate that about 25% of deaths
occurring in the country may be attributed to NCDs.
A study by Hosseinpanah et al2 showed that Asian
countries have a higher prevalence of chronic kidney
disease (CKD). The estimates of CKD prevalence were 14.9%
in Iran, 18.7% in Japan, 13.8% in Thailand and 29.9% in
Pakistan, compared to 11% in the US and 11.2% in Norway.
In Pakistan, according to Jafar et al, approximately 15e20%
of people older than 40 years of age have a reduced esti-
mated glomerular filtration rate.3 The identified risk of
getting CKD is 2.8, 1.93 and 1.63 in people with hyperten-
sion, diabetes and smoking, respectively.4e6 Hypertension
is particularly prevalent in Pakistan, ranging from 17.3% to
25.3% depending on ethnicity.7
Little is known about the epidemiology of depressive
disorders in patients with chronic medical conditions in
Pakistan. Patients with CKD have higher point prevalence of
depression, much like other chronic diseases.8e11 Esti-
mated figures from the US of depressive disorder in CKD
range from 25% to 34%, compared to 5% in the general
population.12,13 The risk factors for major depressive
episodes are urban residency, smoking, alcohol intoxica-
tion, chronic medical conditions, economic difficulties, and
confinement to a bed or chair.14,15 Other reasons for the
increase in depression in CKD patients are colorless diets,
comorbid conditions, curtailed life spans, and clear socio-
economic disadvantage versus the general population.16,17
In the context of Pakistan, one issue stands out star-
klydthe specter of bonded labor. With approximately 34%
of Pakistanis living below the poverty line, many people are
forced into bonded labor in an effort to make ends meet.
Uncertain employment opportunities, multiple dependents
and the addition of debt to an already strained economic
situation create a highly pressured environment in which
depression may fester. It is no wonder then that in recent1561-5413/$36 Copyright ª 2011, Hong Kong Society of Nephrology Ltd
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kidney sales, with many men going under the knife in an
effort to pay off their burgeoning debt. A recent survey
showed that a staggering 93% of people who sold their
kidney did it for debt repayment. With an average monthly
income of US$15, average debt of US$1311 and a kidney
selling for around US$1377, on the face of it, selling
a kidney would appear to be an easy way out of debt.
However, the survey found that 88% experienced no
improvement in their lives following the sale of their
kidney, and 98% reported a deterioration in their general
health status.18 A systematic review by Garg et al showed
an average decline of 26% in glomerular filtration rate
assessed at least a year after kidney donation.19
Although there has been positive legislative action, the
absence of objective data fails to curb the problem. In the
milieu of economic difficulties and social problems like
bonded labor and low literacy, the burden of mental health
problems is bound to be high. There is a dire need to carry
out a nationally representative survey on the burden of
mental health problems in general and CKD in particular,
surveys that should also explore the various risk factors
associated with the problem in order to help develop
a locally relevant interventional strategy.
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